Jensen W A, Fall M Z, Rooney J, Kordick D L, Breitschwerdt E B
Heska Corporation, Fort Collins, Colorado 80525, USA.
J Clin Microbiol. 2000 May;38(5):1717-22. doi: 10.1128/JCM.38.5.1717-1722.2000.
Five species of Bartonella have been reported to infect humans and cause a variety of diseases that can be difficult to diagnose. Four species of Bartonella have been reported to infect cats and dogs, and two of these species are considered to be zoonotic pathogens. Diagnosis of Bartonella infections is hampered by the slow, fastidious growth characteristics of Bartonella species. We report on the development of a single-step PCR-based assay for the detection and differentiation of medically relevant Bartonella species. PCR-mediated amplification of the 16S-23S rRNA intergenic region resulted in a product of a unique size for each Bartonella species, thereby allowing differentiation without the necessity of restriction fragment length polymorphism analysis or sequencing of the amplified product. The ability of the single-step PCR assay to differentiate between Bartonella species was determined with characterized isolates and blood samples from animals known to be infected with either Bartonella henselae, B. clarridgeiae, or B. vinsonii subsp. berkhoffii. The sensitivity of the single-step PCR assay relative to that of in vitro culture was determined with blood samples from B. henselae-infected cats. B. henselae target DNA was amplified from 100% of samples with greater than 50 CFU/ml and 80% of samples with 10 to 30 CFU/ml. The single-step assay described in the report expedites PCR-based detection and differentiation of medically relevant Bartonella species.
据报道,有五种巴尔通体可感染人类并引发多种难以诊断的疾病。据报道,有四种巴尔通体可感染猫和狗,其中两种被认为是人畜共患病原体。巴尔通体生长缓慢且苛求,这使得巴尔通体感染的诊断受到阻碍。我们报告了一种基于单步PCR的检测方法的开发,用于检测和区分医学上相关的巴尔通体物种。PCR介导的16S - 23S rRNA基因间隔区扩增,使得每个巴尔通体物种产生独特大小的产物,从而无需对扩增产物进行限制性片段长度多态性分析或测序就能实现区分。利用已鉴定的分离株以及已知感染了亨氏巴尔通体、克拉氏巴尔通体或文森巴尔通体伯克霍夫亚种的动物的血样,确定了单步PCR检测方法区分不同巴尔通体物种的能力。利用感染亨氏巴尔通体的猫的血样,确定了单步PCR检测方法相对于体外培养的灵敏度。从每毫升大于50菌落形成单位(CFU)的样本中,100%能扩增出亨氏巴尔通体目标DNA;从每毫升10至30 CFU的样本中,80%能扩增出目标DNA。本报告中描述的单步检测方法加快了基于PCR的医学相关巴尔通体物种的检测和区分。